{'fraction_non_alphanumeric': 0.03207547169811321, 'fraction_numerical': 0.03207547169811321, 'mean_word_length': 5.6375, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Effect of Pentadecapeptide BPC 157 on Episcleral Vein Cauterization Model in Rats

Previously, in a short term study, stable gastric pentadecapeptide BPC 157 initially counteracts increased intraocular pressure (IOP) in rats underwent episcleral cauterization (The FASEB Journal, Vo. 30 No.1 supplement 1201.4). Now, in a six month study, rats underwent episcleral cauterization instead continuously exhibiting increased IOP, showed normal intraocular pressure with BPC 157 therapy, given daily, in the whole six month period.